Publications

Export 24135 results:
Sort by: [ Author  (Asc)] Title Type Year
[A] B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
A
Audrain, B., M. A. Farag, C. - M. Ryu, and J. - M. Ghigo, "Role of bacterial volatile compounds in bacterial biology.", FEMS microbiology reviews, vol. 39, issue 2, pp. 222-33, 2015 Mar. Abstract9-farag_et_al._fems_2015.pdf

Bacterial interactions with neighboring microorganisms via production of small metabolites enable bacteria to respond and adapt to environmental changes. The study of intercellular interactions primarily focused on soluble metabolites, but bacteria also produce and release into their headspace a wide variety of volatile secondary metabolites, the ecological roles of which have generally been overlooked. However, bacterial volatile compounds are known to contribute to interkingdom interactions (plant, fungi and nematodes), and recent studies also identified their at-a-distance influence on bacterial behavior. The present review describes the biological roles of bacterial volatile compounds in inter- and intraspecies bacterial interactions, a new and yet unexplored research area, with potential clinical and industrial applications.

Auf, R. A., G. N. Radwan, C. A. Loffredo, E. M. Setouhy, and M. K. Mohamed, Assessment of tobacco dependence, , 2012. Abstract

Waterpipe smoking is increasing worldwide.
Nevertheless, little is known about nicotine dependence
in tobacco smokers who use waterpipes.
OBJECTIVE:To assess evidence of dependence among
non-cigarette smoking waterpipe smokers in Egypt.
METHODS: A total of 154 male exclusive current waterpipe smokers were enrolled for the present study. We
adapted the Fagerström test for nicotine dependence and
the Reasons for Smoking (RFS) scales and related these
to smoking behavior.
RESULTS:The mean age of the subjects was 47±
14 years, the mean age at smoking initiation was 22±
9 years, and average daily consumption was 4± 8 hagars
(tobacco units). The time to the first smoke of the day
(P <0.001), smoking even when ill (P =0.003), time to
tobacco craving (P <0.001), and hating to give up the
first smoke of the day (P =0.033) were each significantly associated with the number of hagars smoked per
day. The RFS subscales of addictive smoking, smoking
to relieve negative affect, and smoking for stimulation
were also associated with these variables.
CONCLUSION: The overall findings suggest that waterpipe smokers exhibit many of the same features of nicotine dependency attributed to cigarette smokers.
KEY WORDS: waterpipe smoking; nicotine dependence;
FTND; RFS; Egypt

Auf, R. A., G. N. Radwan, C. A. Loffredo, E. M. Setouhy, E. Israel, and M. K. Mohamed, Assessment of tobacco dependence in waterpipe smokers in Egypt, , 2012. shisha_addiction_2012.pdf
Aufy, S. M., A. M. A. Mahgoub, M. G. E. - D. Saadi, and M. A. Elmallawany, "Serological Detection of Toxoplasma gondii in Chronic Renal Failure Patients and Renal Transplant Recipients", Journal of the Egyptian Sociaty of Parasitology, vol. 39, issue 3, pp. 943-950, 2009.
Aufy, S. M., A. M. A. Mahgoub, M. G. E. - D. Saadi, and M. A. Elmallawany, "Serological detection of Toxoplasma gondii in chronic renal failure patients and renal transplant recipients.", Journal of the Egyptian Society of Parasitology, vol. 39, issue 3, pp. 943-50, 2009. Abstract

Toxoplasma gondii antibodies were detected in 78 patients with renal disease by ELISA. Patients were classified according to the renal status; chronic renal failure patients not on haemodialysis (G1 = 19), chronic renal failure patients on regular haemodialysis (G2 = 30), renal transplant recipient (G3 = 29) and 13 normal controls. Anti-Toxoplasma IgG & IgM antibodies were 36.8% & 10.5% in renal failure patients not on haemodialysis, 56.7% &16.7% in patients on regular haemodialysis and 69% & 24.1% in renal transplant recipients versus 23.1% & 0% in controls with statistical significant difference for Toxoplasma IgG antibodies only. Anti-Toxoplasma IgG antibodies levels of G3 were lower than that of G1. It was observed that the more the exposure to dialysis, the more the risk of toxoplasmosis. It was found that 85.71% of renal transplant recipient seropositive cases for anti-Toxoplasma IgM antibodies were detected in one year post-transplantation and 14.28% of cases after the first year of transplantation.

Aufy, S. M., A. M. A. Mahgoub, M. G. E. - D. Saadi, and M. A. Elmallawany, "Serological detection of Toxoplasma gondii in chronic renal failure patients and renal transplant recipients.", Journal of the Egyptian Society of Parasitology, vol. 39, issue 3, pp. 943-50, 2009 Dec. Abstract

Toxoplasma gondii antibodies were detected in 78 patients with renal disease by ELISA. Patients were classified according to the renal status; chronic renal failure patients not on haemodialysis (G1 = 19), chronic renal failure patients on regular haemodialysis (G2 = 30), renal transplant recipient (G3 = 29) and 13 normal controls. Anti-Toxoplasma IgG & IgM antibodies were 36.8% & 10.5% in renal failure patients not on haemodialysis, 56.7% &16.7% in patients on regular haemodialysis and 69% & 24.1% in renal transplant recipients versus 23.1% & 0% in controls with statistical significant difference for Toxoplasma IgG antibodies only. Anti-Toxoplasma IgG antibodies levels of G3 were lower than that of G1. It was observed that the more the exposure to dialysis, the more the risk of toxoplasmosis. It was found that 85.71% of renal transplant recipient seropositive cases for anti-Toxoplasma IgM antibodies were detected in one year post-transplantation and 14.28% of cases after the first year of transplantation.

AUMA, J., and M. Hashem, "Studies on substances with sex pheromone activity produced by Heterodera schachtii females", Fundam. appl. Nematol, vol. 16, issue 1, pp. 43-46, 1993. Abstract
n/a
Aurer, I. a, H. b Eghbali, J. c Raemaekers, H. M. d Khaled, C. e Fortpied, L. e Baila, and R. W. c Van Der Maazen, "Gem-(R)CHOP versus (R)CHOP: A randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma - EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54)", European Journal of Haematology, vol. 86, no. 2, pp. 111-116, 2011. AbstractWebsite

Background: Despite recent improvements, many patients with aggressive non-Hodgkin's lymphoma (NHL) ultimately succumb to their disease. Therefore, improvements in front-line chemotherapy of aggressive NHL are needed. Gemcitabine is active in lymphoma.Methods: We performed a randomized phase II trial of the addition of gemcitabine to standard CHOP chemotherapy with or without rituximab [(R)CHOP]. The trial was also designed to determine the maximal tolerated dose (MTD) of gemcitabine in this combination. Patients with previously untreated aggressive NHL were randomized to receive either eight cycles of (R)CHOP given every 3 wk or (R)CHOP combined with gemcitabine [Gem-(R)CHOP].Results: Twenty-five patients were enrolled in the trial before early closure. Twelve were randomized to Gem-(R)CHOP and 13 to (R)CHOP. MTD of gemcitabine was 800 mg/m2 given on days 1 and 8; dose-limiting toxicity was hematologic. Five patients (42%) treated with Gem-(R)CHOP achieved complete response in comparison with 10 (77%) treated with (R)CHOP. Median time to treatment failure was 1.5 yr for Gem-(R)CHOP and 3.1 yr for (R)CHOP. Three patients receiving Gem-(R)CHOP had serious pulmonary toxicity, when compared to none receiving (R)CHOP. One patient died of pneumonitis.Conclusions: In this group of patients, addition of gemcitabine did not seem to improve outcomes. Gem-(R)CHOP in previously untreated patients with aggressive NHL occasionally results in severe, potentially fatal, pulmonary toxicity. © 2010 John Wiley & Sons A/S.

Aurer, I., H. Eghbali, J. Raemaekers, H. M. Khaled, C. Fortpied, L. Baila, and R. W. M. van der Maazen, "Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54).", European journal of haematology, vol. 86, issue 2, pp. 111-6, 2011 Feb. Abstract

BACKGROUND:   Despite recent improvements, many patients with aggressive non-Hodgkin's lymphoma (NHL) ultimately succumb to their disease. Therefore, improvements in front-line chemotherapy of aggressive NHL are needed. Gemcitabine is active in lymphoma.

METHODS: We performed a randomized phase II trial of the addition of gemcitabine to standard CHOP chemotherapy with or without rituximab [(R)CHOP]. The trial was also designed to determine the maximal tolerated dose (MTD) of gemcitabine in this combination. Patients with previously untreated aggressive NHL were randomized to receive either eight cycles of (R)CHOP given every 3 wk or (R)CHOP combined with gemcitabine [Gem-(R)CHOP].

RESULTS: Twenty-five patients were enrolled in the trial before early closure. Twelve were randomized to Gem-(R)CHOP and 13 to (R)CHOP. MTD of gemcitabine was 800 mg/m(2) given on days 1 and 8; dose-limiting toxicity was hematologic. Five patients (42%) treated with Gem-(R)CHOP achieved complete response in comparison with 10 (77%) treated with (R)CHOP. Median time to treatment failure was 1.5 yr for Gem-(R)CHOP and 3.1 yr for (R)CHOP. Three patients receiving Gem-(R)CHOP had serious pulmonary toxicity, when compared to none receiving (R)CHOP. One patient died of pneumonitis.

CONCLUSIONS: In this group of patients, addition of gemcitabine did not seem to improve outcomes. Gem-(R)CHOP in previously untreated patients with aggressive NHL occasionally results in severe, potentially fatal, pulmonary toxicity.

of the auricle, R., Reconstruction of the auricle, , Cairo, Cairo, 1999. image.png
author, A. E. E. M., M. Samer, Y. A. Attia, M. A. Abdel-Hadi, H. E. Hassan, and Y. Badr, "Effects of Laser Irradiation and Ni Nanoparticles on Biogas Production from Anaerobic Digestion of Slurry", Waste and Biomass Valorization, vol. 10, issue 11, pp. 3251–3262, 2019.
Author, S. A. H., E. Nabil, and A. A. Badr, "Detection of Visual Positive Sentiment using PCNN", International Journal of Advanced Computer Science and Applications(IJACSA), vol. 10, issue 1, pp. 258-262, 2019.
authors, 66, and M. E. E. K. amr and Editors:Samir Galal, Kasr El-Aini Introduction To Surgery,3rd -7th Editions, , Cairo, University Book Center,Sayed mahmoud, 2010.
Avaji, M., J. S. Hafshejani, S. S. Dehcheshme, and D. F. Ghahfarokh, "Solution of delay Volterra integral equations using the Variational iteration method", Journal of Applied Sciences, vol. 12, no. 2, pp. 196–200, 2012. Abstract
n/a
Avaji, M., J. S. Hafshejani, S. S. Dehcheshme, and D. F. Ghahfarokh, "Solution of delay Volterra integral equations using the Variational iteration method", JApSc, vol. 12, no. 2, pp. 196–200, 2012. Abstract
n/a
Avaji, M., J. S. Hafshejani, S. S. Dehcheshmeh, and D. F. Ghahfarokhi, "Solution of delay Volterra integral equations using the Variational iteration method", Journal of Applied Sciences(Faisalabad), vol. 12, no. 2: Asian Network for Scientific Information, 308-Lasani Town Sargodha Rd …, pp. 196–200, 2012. Abstract
n/a
Avella, A. B. -, R. Hotakainen, M. A. Shehhi, A. Urzi, L. A. M. Selim, and N. A. Menabawy, "A disorder clinically resembling cystic fibrosis caused by biallelic variants in the AGR2 gene", journal of medical genetics, pp. 1-9, 2021. jmedgenet-2021-108150.full_.pdf
Avison, D., A. Wood-Harper, R. Vidgen, and J. Wood, "A further exploration into information systems development: {The} evolution of {Multiview}2", IT and People, vol. 11, pp. 124–139, apr, 1998. Abstract
n/a
Avison, D. E., and G. Fitzgerald, Information {Systems} {Development}: {Methodologies}, {Techniques} and {Tools}, , 2nd, London, McGraw-Hill, 1995. Abstract
n/a
Avramovic-Cingara, G., C. A. R. Saleh, M. Jain, and D. Wilkinson, "Void Nucleation and Growth in Dual-Phase Steel 600 during Uniaxial Tensile Testing", Metallurgical and Material transactions A, , vol. 40, , issue 13, 2009, pp. 3117-3127, 2009.
Awaa, M. H. H., A. Atta, M. A. Ali, and S. A. Zoulfakar, "Effect of Pediococcus Acidilactici Supplementation", XIV th European Poultry Conference pp 483. , Stavagner, Norway , 23-27 June 2014,. effect_of_pediococcus_acidilactici_supplementation.docx
Awaad, A. S., D. J. Maitland, A. M. Donia, A. I. Hashem, G. A. Soliman, V. K. Singh, J. N. Govil, and others, "New antioxidant flavonoids from Atriplex lentiformis (Torr.) S. Wats.", Phytopharmacology and therapeutic values V: Studium Press LLC, pp. 47–57, 2009. Abstract
n/a
Awaad, M. H. H., S. M. M. Shalash, H. B. A. Atta, Ghareb, M. A. ELMenawey, M. A. Ali, S. A. Zouelfekar, F. Fathy, M. Elhariry, A. Samir, and V. Demy, "Evaluation of the efficacy of Saccharomyces cerevisiae boulardii on performance, intestinal microbiota and gut integrity of broiler chickens in challenging conditions.", 11th APPC Bangkok, Thilland, 2018. Abstract
n/a
Awaad, M. H. H., M. A. ELMenawey, B. Shalaby, F. F. Mohamed, A. M. Nada, H. Salem, E. A. Morsy, and S. Lopez, "Opposing of Necrotic Enteritis by Phytonutrients and/or Acidifiers in Broiler Chicken", Journal of Agriculture and Veterinary Science, vol. 12, issue 3, pp. 12-21, 2019. Abstract
n/a